Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial - 2ABC News' Sam Champion opens up about recent health scare
- 3The Best Web-based Courses for Expertise Improvement
- 4German economic institutes cut forecast in half over Iran war
- 5In these U.S. groups, deaths now exceed births. What’s happening?
- Pain at the pump for Hampton Roads residents
- What's changing about healthcare in 2026 — Medicare, Medicaid, ACA, premiums, and enrollment deadlines
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- Extreme Manual for Picking a Camper Van
- Death toll from floods in Afghanistan rises to 61
- Melodic Event: A Survey of \Energies and Exhibitions Assessed\ Live concert
- No respite for German economy as experts slash forecast over Iran war
- Partake in the Outside: Senior-Accommodating Exercises for 2024
